Back
Xvivo Perfusion AB Vs. UniFirst Industry Stock Comparison
Buy
71
XVIPF
Xvivo Perfusion AB
Last Price:
$44.60
Seasonality Move:
-0.25%
Buy
73
UNF
UniFirst
Last Price:
$214.87
Seasonality Move:
1.02%
Buy
71
Xvivo Perfusion AB (XVIPF)
is a Buy
Is Xvivo Perfusion AB a Buy, Sell or Hold?
-
The current Xvivo Perfusion AB [XVIPF] share price is $44.60. The Score for XVIPF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
XVIPF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XVIPF Stock Price Chart
What is Xvivo Perfusion AB's stock price today?
-
The Xvivo Perfusion AB share price today is $44.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XVIPF is experiencing slight buying pressure.
XVIPF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.3 | Buy |
Relative Strength Index (14 RSI): | 67.24 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.96 - 43.62) | Buy |
Bollinger Bands (100): | (41.86 - 48.96) | Sell |
UNF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 72.95 | Buy |
Chaikin Money Flow: | 380542 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (173.47 - 198.41) | Buy |
Bollinger Bands (100): | (180.75 - 197.95) | Buy |
XVIPF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.58 | Buy |
20-day SMA: | 42.14 | Buy |
50-day SMA: | 42.21 | Buy |
200-day SMA: | 41.99 | Buy |
8-day EMA: | 43.17 | Buy |
20-day EMA: | 42.47 | Buy |
50-day EMA: | 42.97 | Buy |
200-day EMA: | 41.05 | Buy |
UNF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 180.62 | Buy |
20-day SMA: | 183.05 | Buy |
50-day SMA: | 190.15 | Buy |
200-day SMA: | 178.74 | Buy |
8-day EMA: | 187.59 | Buy |
20-day EMA: | 185.11 | Buy |
50-day EMA: | 187.72 | Buy |
200-day EMA: | 182.46 | Buy |
Xvivo Perfusion AB Earnings Growth & XVIPF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
UniFirst Earnings Growth & UNF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.98 per share, a decrease this year of $0.14 per share, and an increase next year of $0.92 per share.
Xvivo Perfusion AB Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
UniFirst Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |